drugset / Trial / NCT06609941

Additive Effects of Alternative Nostril Breathing with Pharmacological Management on Dyspnea and Control Pause in Patients with Bronchial Asthma

NCT06609941

Recruiting 32 enrolled Foundation University Islamabad
RandomizedParallel-groupOpen-labelTreatment

Summary

Bronchial asthma is a widespread chronic condition charactrized by inflammation and narrowing of airways, leading to repeateted episodes of breathlessness, wheezing and labored breathing.Breathing exercises help to manage hyperventilation often seen in asthmatic patients. To handle respiratory complications asthmatics are advised to practise nasal breathing techniques in conjunction with their prescribed medications.

Timeline

Start
2024-06-18
Primary completion
2025-01-01
Completion
2025-02-01

Drugs

EvaluationDrugModalityDoseRoute
Background Lamivudine Other / unclassified
Background Salbutamol Unknown Inhaled
Background Saltra Unknown Inhaled
Background Tiotropium Other / unclassified

Indications